Severe Sepsis Completed Phase 3 Trials for Sargramostim (DB00020)

Also known as: Sepsis, Severe

IndicationStatusPhase
DBCOND0031268 (Severe Sepsis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02361528GM-CSF to Decrease ICU Acquired InfectionsTreatment